Meet the American Liver Foundation’s New CEO, Lorraine Stiehl
It is both an honor and a privilege to be able to serve all of you in our liver community. After three decades of working with health non-profits, academic medical institutions and advocacy groups, I am humbled to be asked to lead the American Liver Foundation (ALF). I look forward to working with all of you.
For much of my professional life, I’ve been focused on helping to solve the twin public health challenges of type 2 diabetes and obesity, as well as the challenges involving autoimmune diseases including type 1 diabetes. Since type 2 diabetes is often driving non-alcoholic fatty liver disease and NASH – plus a growing area of liver disease involves autoimmunity, I feel at home in the liver space. Let’s break down the silos that exist between organs and their related diseases – and create greater synergistic partnerships, all for the benefit of patients.
I am also grateful to have experienced the complex yet rewarding organ transplantation process though my husband’s living donor kidney transplant. One of life’s most meaningful transactions is the exchange of an organ – a remarkable “gift of life.” As your new leader, I will make sure ALF and our transplant partners do all we can to increase the rate of liver donation including living donor liver transplant. It isn’t acceptable to have thousands of people waiting for donor organs. We must do more.
As we all know, the pandemic has been tough for everyone. Besides the tragic hardship and loss of life across the globe, thousands of non-profits have failed. We should all feel proud that the leadership of the American Liver Foundation took immediate and decisive action to restructure the organization, ensuring its future sustainability. As the American Liver Foundation launches its 45th year, our ability to support the liver community remains strong.
Special thanks to my dedicated predecessor Tom Nealon for introducing me to the American Liver Foundation and for his inspirational leadership. Also, I am grateful for our recently retired Executive Vice President and Chief Operating Officer Lynn Seim, MSN, RN for her programmatic vision and management successes. Also, special thanks to former Board Chair Nick DeRoma who continues to be a trusted advisor, and current Board Chair Dan Weil who serves as my valued partner. Paraphrasing Sir Isaac Newton, “I can see further by standing upon the shoulders of giants.”
Again, I’m grateful for this opportunity to serve our liver community. Please reach out to me with your thoughts, questions and concerns: firstname.lastname@example.org.
Chief Executive Officer
American Liver Foundation
Share this page